In a rare case, a 29-year-old man was successfully operated for a tumor in his windpipe, at Indraprastha Apollo Hospitals, New Delhi. Initially, the patient had complained of chest pain and progressive swelling in his neck. After suffering for over 2 months he consulted a local doctor who diagnosed him with Tuberculosis, but his condition did not improve with TB medication. As next steps he underwent bronchoscopy that revealed a large mass in his windpipe causing 80% blockage. With his condition deteriorating due to acute breathlessness and fluctuating oxygen levels he was admitted to a local hospital of Faridabad. With no respite in his condition he was referred to Indraprastha Apollo Hospitals, New Delhi where he was admitted under the supervision of Dr Nikhil Modi, Senior Consultant, Respiratory and Critical Care Medicine, Indraprastha Apollo Hospitals, New Delhi. Here, he was immediately put on ventilator to first stabilise his oxygen level. However, when further examined by Dr Suresh Singh Naruka, Senior Consultant, ENT and Head and Neck Surgeon, Indraprastha Apollo Hospitals, New Delhi for his tumor, he was recommended an immediate tumor removal surgery. Dr Suresh Singh Naruka, Senior Consultant, ENT and Head and Neck Surgeon, Indraprastha Apollo Hospitals, New Delhi said, “When this patient was admitted to Apollo he had developed a tumour which was causing 80% blockage of the neck. Hence after stabilizing his oxygen levels an immediate surgery was carried out in order to maintain the airway. This surgery in particular was challenging. Due to the size of the tumor, there was no space for air to pass into the lungs and patient saturation rate was dropping very fast whenever we were doing any instrumentation. The procedure took 3 hours but we were able to successfully remove the tumor. Post-operatively the patient was kept in ICU for further monitoring and as he was successfully weaned off from mechanical ventilation, he was discharged on 9th November, 2022. Post-surgery, the biopsy of wind pipe mass revealed a cancer of lymphoid cells known as Lymphoma. Lymphoma is extremely rare to find in wind pipe as it comprises only 0.2% to 0.3% of all wind pipe tumors. Basis the presence of lymphoma he is undergoing chemotherapy as further management and is keeping well now.” Speaking on the same, Dr Nikhil Modi, Senior Consultant, Respiratory and Critical Care Medicine, Indraprastha Apollo Hospitals, New Delhi said, “Early and correct diagnosis has the best opportunity for a positive heath outcome. Sometimes, with patient getting delayed medical care the condition can become life-threatening. Same was the case with this 29-year-old man from Uttar Pradesh, due to delay in treatment & wrong diagnosis, the tumor increased in size and caused nearly complete blockage of the wind pipe. With his condition deteriorating he was admitted on 29th October, 2022 at Indraprastha Apollo Hospitals. To maintain his airway, he underwent urgent tracheostomy and bronchoscopy followed by tumor removal surgery.” The patient is still visiting the hospital for follow-up and management of Lymphoma through chemotherapy.

Apollo Proton Cancer Centre has successfully performed Asia’s first brain bypass surgery on twin 8-year-old children from the Netherlands diagnosed with Moyamoya disease. The integration of advanced technology and expertise at APCC helped the children to undergo surgery and recover quickly. Dr. Roopesh Kumar, Senior Consultant, Neurosurgeon, Apollo Proton Cancer Centre said “When we first met the two young girls with Moyamoya disease, the team was determined to do the very best to save those two precious lives. The surgery to ensure good blood flow in the left brain and reduce the chances of strokes to a minimum, was successful. I am extremely delighted with their recovery and glad that our efforts to address the Moyamoya disease were successful. The timely decision to perform this complex surgery helped in saving lives at the right time. At APCC, high-risk cases are managed in a specialised tertiary centre with excellent facilities. The advanced surgical techniques and availability of technology in combination with expertise improves the chances of saving a patient’s life even with critical complications.” Read more how twins’ lives were saved by doctors at APCC

With a focus on innovating new techniques for the treatment of rare cancer cases, Apollo Cancer Centre, Bangalore, has been at the forefront of battling cancer with advanced care. Apollo’s vision is to deliberate the emerging trends in cancer management and their impact on clinical practice thus bringing a ray of hope to 3.5 billion people from over 147 countries. Dr Satish Nair, Senior Consultant, ENT & Head and Neck Oncology, Apollo Cancer Centre, Bangalore, along with a team of medical experts performed an endoscopic trans canal excision of facial nerve schwannoma on a 35-year-old patient who was suffering from right-sided facial weakness for the last two years. This is for the first time in the world that the principles of head and neck, lateral skull-base approach, and endoscopic techniques were used together to retain the entire functionality of the ear. The team did an otoendoscopy that revealed a pinkish-pale non-pulsatile mass behind the intact tympanic membrane at the posterosuperior quadrant. Further examination showed that the patient had right-sided Grade V lower motor neuronal facial palsy and the high-resolution computed tomography of Temporal Bone revealed a mass in the facial recess eroding the posterior genu of the facial nerve, which suggests facial nerve schwannoma. The surgery lasted for two hours wherein the team of doctors performed endoscopic trans canal excision of facial nerve schwannoma with cable grafting using the greater auricular nerve. The patient was discharged on the second post-operative day without any complications. Read more about World’s first Endoscopic Transcanal Excision of Facial Nerve Schwannoma performed at Apollo Cancer Centre, Bangalore.

A 64-year-old gentleman from Fiji recently Robot-Assisted Total Arterial Bypass Surgery for Triple Vessel Coronary Artery disease at Indraprastha Apollo Hospitals, Delhi. He had been suffering from chest discomfort for the past 2 years and had an uncontrolled blood sugar levels and impaired kidney function. Additionally, on examination he was also diagnosed with moderate heart dysfunction- his heart was not pumping enough blood, which put him at the risk of heart failure. The patient had been advised an open heart surgery in his native country, however he was skeptical due to the possibilities of multiple complications involved like chest bone being cut, blood loss, kidney failure and post-surgical recovery. The surgery would be challenging because the patient had multiple underlying co-morbidities, hypertension, unstable sugar levels and lower heart function. With his condition deteriorating and taking a toll on his overall health, he was referred to Indraprastha Apollo Hospitals, New Delhi. He was admitted under the supervision of Dr MM Yusuf, Specialist Consultant, Robotics and Minimally Invasive Cardiac Surgery, Dr Mukesh Goel, Senior Consultant, Cardiothoracic Surgery & Dr Varun Bansal, Consultant, Robotics and Minimally Invasive Cardiac Surgery, Indraprastha Apollo Hospitals. As a first step, patient was admitted at the hospital for 5 days prior to the surgery to stabilize his kidney function. Once he was stabilized, the team of doctors conducted the robot-assisted total arterial triple vessel coronary artery bypass surgery. Post-surgery, he was kept for observation in the ICU and then discharged. Currently, he is stable and walking around without support and performing all regular activities independently. Dr MM Yusuf, who led the robot assisted surgery, said, “Robotic assist CABG is the least invasive cardiac procedure. It is a symbiosis between state-of-the-art technology and surgical expertise. It offers great short and long-term benefits by subjecting patients to minimal cuts, less bleeding, less pain, early recovery and quick return to active life. Total arterial bypass surgery also provides best long term outcome with less risk of re-intervention later in life. Dr MM Yusuf & his team have been performing this procedure routinely at Apollo Hospitals, Chennai over the past 2 years. Speaking about the procedure, Dr Mukesh Goel said, “While fewer acute heart attack cases are being admitted to hospital emergency units, there is a marked increase in deaths from cardiac arrest at home, probably due to the postponement and delay in seeking medical attention. It is, therefore, important to emphasize that heart patients must not ignore any deterioration in symptoms and/or delay medical attention. Apollo Hospitals have been known to introduce the latest medical technology in India for the benefit of the patients. Minimally invasive cardiac surgery avoids sternal split and aids in a quick recovery”. Dr Varun Bansal added,” Technology has ushered in a paradigm shift in healthcare. From performing complex surgeries to providing remote care with telehealth, it has brought a massive transformation, taking medical treatment to unimaginable heights. Even though the use of robots in surgery isn’t new, emerging technologies and innovations have expanded their scope to help doctors perform difficult medical procedures and surgeries easily with more precision, comfort and speed.” Following this patient from Fiji, another patient from India, who had coronary artery disease also underwent Robotic assist total arterial triple vessel bypass surgery and has reclaimed his active life within a week.

A 60-year-old man, citizen of Nigeria, successfully underwent a high risk and rare surgery for total femur replacement of the whole of thigh bone with knee and partial hip at Indraprastha Apollo Hospitals in New Delhi. Femur replacement surgery is a salvage arthroplasty procedure used as an alternative to lower limb amputation. It is characterized by limb preservation, faster and quality rehabilitation. Total Femur replacement surgeries are done for patients who have undergone cancer related treatment in the past or pathologic fracture of a previously fixed femur which does not get better by other procedures. In this case the patient, Mr. Onah, had been undergoing treatment for recurrent giant cell tumor for the past 12 years. He had undergone two surgeries in South Africa in 2010 following which tumor excision and mega prosthesis was done at Indraprastha Apollo Hospitals in 2013 followed by a revision in 2016. On his recent follow up consultation his reports revealed that he required Total Femur replacement prosthesis. He was admitted at Indraprastha Apollo Hospitals on 17th September and on the same day in a 5 hour long procedure, a total femur replacement was done by Dr Yash Gulati, Senior Consultant Orthopedics, Joint Replacement & Spine, Indraprastha Apollo Hospitals, New Delhi and his team of surgeons. Dr Yash Gulati, Senior Consultant Orthopedics, Joint Replacement & Spine, Indraprastha Apollo Hospitals, New Delhi says that, “Administering a Total Femur Replacement surgery to Mr. Onah, who has undergone tumor excision and mega prosthesis procedures in the past, was challenging. Very few hospitals in the country are equipped to conduct such a complicated procedure. However, the state of the art facility at Indraprastha Apollo Hospitals enabled us to undertake this procedure and save a life. The surgery was high-risk as the patient had multiple surgeries in the same region before and had a big tumor operated three times in the same area along with a total of 5 surgeries earlier. There was a risk of embolism as he was not in a mobile condition for several months. Additionally, there was also a big risk of dislocation due to the lack of proper tissue support. The surgery was the last resort and another alternative option would have been to do an amputation of the whole lower limb. The reason for the ailment was a tumor which Mr. Onah had at the lower end of femur and was operated twice in South Africa and had appeared again. The procedure and post-surgical recovery of Mr Onah was uneventful and after a week the patient was able to move with support. He was discharged on 22nd September. As a treatment modality, he shall be administered regular post-operative physiotherapy for a couple of months.

Apollo Hospitals, Seshadripuram, Bangalore has introduced India’s very first Moses 2.0 Laser, an advanced and novel laser technology to treat prostate enlargement and kidney stones even in high risk patients with multiple health complications like diabetes, hypertension, cardiac issues. It’s a completely bloodless and painless procedure which takes less time with utmost precision. It reduces hospital stay and has a fast post-procedure recovery. Introduced just about 3 months back on the global healthcare map, Moses 2.0 is a modification of Holmium laser technology (which has been in use for about 15 years in healthcare) that auto modulates to prevent bleeding during surgery, which makes it a game changer technology to treat enlarged prostate and kidney stones for those who have multiple health risks and who are on blood thinners or anticoagulants. It uses a high power Holmium laser of 120 watts. India is one among the few countries to get Moses 2.0. For the first time in India, Moses 2.0 is installed at Apollo Hospital, Seshadripuram, Bengaluru, which has become a Centre of Excellence in Urology. When Moses technology is used in prostate treatment, it is called Moses Laser Enucleation of the Prostate (MOLEP) and to treat stones, it is called Moses Laser Technology Fragmentation (MLTF). Explaining the benefits of this latest technology for both prostate enlargement and kidney stone removal, Dr Manohar T, Chief of Urology, Uro Oncology, Laser, Laparoscopic, Transplant and Robotic Surgery at Apollo Hospital Seshadripuram and Director, said: “Procedures conducted with Moses 2.0 Laser are endoscopic and do not involve cut opening of the area. The best part is that prostate of any size can be completely treated, while stones get totally fine dusted without any possibilities of any fragments remaining. In this procedure about 90% of the prostate is removed as against conventional methods that take out only 40% to 50% of the enlarged prostate. There is no bleeding or pain caused to the patient and no risk of regrowth of prostate. “It is a minimally invasive, painless with no bleeding and brings down the duration of hospital stay, making recovery quicker. It can also be used to treat enlarged prostate of any size of (as much as 675 grams of prostate which is the largest in the world) and kidney stones (as much as 4.5 to 6.5 cms) and on patients with high risk with hypertension, diabetes, brain stroke and those who are still recovering from complex surgeries and are on blood thinners and anticoagulants. While earlier we had to stop blood thinners on patients for about 5 to 7 days for prostate removal and kidney stone surgeries, Moses laser does not require to stop blood thinners for conducting these surgeries. It doesn’t leave any scar and doesn’t cause any shockwaves or use any puncture methods,” he added. Surgeons require extensive training as Moses 2.0 is technically complicated and demands great technical skills and expertise. Dr Manohar T, the principal investigator on Moses 2.0, with an experience of 16 years on laser, has been studying this unique technology for 2.5 years and have conducted 36 surgeries using Moses 2.0 technology in three months’ time, and has been leading a structured training program at Apollo Hospital, Sheshadripuram. Surgeons from the UK, Sri Lanka, Nepal, Bahrain come here to get hands-on training on Moses 2.0 on advanced simulators that are imported from the USA. These trainee surgeons need to observe 20 cases, assist in 20 other cases and perform another 20 cases before they start performing this procedure independently. “For surgeons, Moses 2.0 makes any surgery very fast, accurate, precise, satisfying and helps them overcome the inhibitions of conducting a complex surgery in no time,” said Dr Manohar T. Mr. Uday Davda, COO at Apollo Hospitals, Seshadripuram, said: “It is a matter of great privilege and honor for us to be a part of this game changing breakthrough in Urology. Apollo Hospital has always been a pioneer in driving technology innovations in India’s healthcare and Moses 2.0 will certainly revolutionize enlarged prostate treatment and kidney stone removal procedures providing optimal clinical outcomes on high risk patients.”

Apollo Hospitals, Navi Mumbai has announced the completion of 53 life-saving pediatric liver transplant surgeries at a special press conference. The Hospital has undertaken total 170 Liver transplants as on date, of which 34 are Cadaver & 12 are International. The significant landmark was achieved in five years and is a testament to the success of Apollo’s Advanced Pediatric Liver Transplant Program in giving a new lease of life to children suffering from end-stage liver disease. The ages of the transplant recipients ranged from a 4-month infant to older children with conditions that included biliary atresia & congenital liver disease leading to liver failure. The pediatric liver transplants included those carried out during the challenging pandemic period and were possible due to the experienced pediatric liver transplant team that followed all necessary global protocols to ensure a safe and uneventful recovery for the transplant recipients. Apollo Hospitals also announced the expansion of its existing Liver Program within the state of Maharashtra & Gujarat under the Clinical leadership of Prof Darius Mirza, an internationally renowned Hepatobiliary Pancreatic Transplant Surgeon with over 35 years of experience, as Chief Consultant HPB & Liver Transplant Program – Apollo Hospitals Western Region. Prof Darius has been associated with Apollo Hospitals for the past 4 years. He recently transitioned out of Birmingham Children’s Hospital UK, where he was a Professor of Hepato-pancreato-biliary Transplant Surgery and was recognized for his outstanding contribution by the European Liver and Intestine Transplant Association. His vast global experience in advanced liver transplant surgery will be of immense benefit to patients in India with end-stage liver disease. The occasion also saw the announcement of an MoU between Apollo Hospitals, Navi Mumbai and Bombay Hospital that will increase access to Apollo’s advanced liver transplant program for patients across the Mumbai Metropolitan Region. The collaboration between the two leading super-specialty hospitals will go a long way in ensuring positive outcomes in liver transplantation for patients with end-stage liver disease. The two institutions would work to build a successful liver transplant program that brings the best of medical expertise and the latest world-class technological advances in liver transplant care to Western India. Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Group said, “It is a proud moment for Apollo as we achieve this milestone of 53 pediatric liver transplants in five years. Apollo performs 15% of India’s liver transplants every year and is a pioneer in solid organ transplants. With an experience over 3 decades in transplants, which include 4,051 livers, Apollo Hospitals has served patients from over 50 countries. We continue to attract the best medical talent as is evident with Prof. Darius Mirza coming on board once again to head the HPB and Liver transplant unit. I also welcome the collaboration with Bombay Hospital, it is tie-ups such as these that will help us deliver our services to a larger section of the populace.” Mr. Santosh Marathe, Regional CEO – Western Region, Apollo Hospitals said, “Apollo Hospitals, Navi Mumbai is a JCI accredited 500 beds quaternary care hospital. The Hospital runs a very successful Transplant program covering Liver, Kidney & Heart. The transplant program is led by a multi-disciplinary team of qualified & experienced clinicians having undertaken significant liver & HPB work. Apollo Hospitals, Navi Mumbai has also undertaken efforts to increase organ donation awareness along with extended outbound liver transplants, training the peripheral hospitals into organ retrieval centers. With the expanded clinical team, citizens from Maharashtra & Gujarat will be immensely benefitted. The Bombay Hospital collaboration will further provide a good opportunity to treat patients with end-stage liver failure symptoms” Prof Darius Mirza, Chief Consultant HPB & Liver Transplant Program – Apollo Hospitals Western Region said, “When I was given the opportunity to develop the liver transplant programme at Apollo Hospitals, I found it the most appropriate center to utilize my expertise of providing a full range of liver transplant care to patients from all age groups and different risk levels” “The pediatric liver transplant programme at Apollo Hospitals has also seen significant fundraising initiatives through tie-ups with financial-aid programs and NGOs. This allows deserving children from underprivileged strata of society to access the best treatment for their condition. The support also extends to post-transplantation medication support.” Dr. Rajkumar Patil, Director-Medical Services, Bombay Hospital and Medical Research Centre, said, “Started in 1952, Bombay Hospital & Medical Research Centre is a 750 bedded hospital, providing relentless and selfless medical services to the common people for the last 6 decades. Bombay Hospital had been planning for a liver transplant programme and few of the patients registered with us have already undergone treatment at Apollo Hospitals, Navi Mumbai. We are happy to collaborate with Apollo Hospitals for the liver transplant program & this will build internal capability of our clinicians & team.”

Mrs. Margaret, a 57-year-old lady from Kenya underwent successful treatment for stage IV endometrial cancer (A cancer of inner lining of uterus) with chemotherapy and immunotherapy at Indraprastha Apollo Hospitals, Delhi. The patient had been suffering from endometrial cancer for the past 1 year and was operated in her native country Kenya in November, 2021. However, the disease spread to other organs and the patient developed additional complications involving extensive disease in the abdomen and pelvis, fluid in both lungs, liver metastasis, a non-healing surgical wound in the abdomen and clots in her legs. With her condition deteriorating and disease taking a toll on her overall health she was referred to Indraprastha Apollo Hospitals, New Delhi where she was admitted under the supervision of Dr Shuaib Zaidi, Senior Consultant, Surgical Oncologist at Indraprastha Apollo Hospitals, New Delhi. As a first step, she was given chemotherapy under the able guidance of Dr Ajay Gupta, Senior Consultant, Medical Oncology, Indraprastha Apollo Hospitals, New Delhi. Speaking on the same Dr Shuaib Zaidi, Senior Consultant, Surgical Oncologist at Indraprastha Apollo Hospitals, New Delhi said, “Endometrial cancer is the cancer of the inner lining of uterus. Often it is diagnosed at an early stage due to frequent abnormal vaginal bleeding but in few cases it can reach to Stage IV without being diagnosed. In most cases of stage IV endometrial cancer, the cancer can spread too far to be removed with surgery and so needs chemotherapy and immunotherapy for treatment. This was the case with Mrs. Margaret, from Kenya who presented with extensive peritoneal deposits in abdomen and pelvis, chest nodes, fluid in both lungs, extensive disease in liver, a non-healing surgical wound and clots in both legs after surgery of Stage IV Endometrial cancer. On admission, the patient was very weak and fatigued due to multiple health complications. She was admitted in the hospital on 20th January, 2022 for initial management of disease but with her condition deteriorating due to large volume of disease she was advised chemotherapy with immunotherapy. So far, in world literature such an excellent response to low dose immunotherapy and chemotherapy has not been described in endometrial cancer.” Talking about the care Dr Ajay Gupta, Senior Consultant, Medical Oncology, Indraprastha Apollo Hospitals, New Delhi said, “On admission at Indraprastha Apollo Hospitals, Mrs. Margaret was very weak and was unable to walk. She needed chemotherapy to combat the widespread disease process. Considering her poor general condition, we started her on weekly chemotherapy. Post two months of therapy, she showed reasonable physical improvement and the disease process had stabilised. The PET scan was also showing stable disease. However, there was a danger that this high risk disease might progress when the chemotherapy was stopped. To circumvent this problem, we utilized a novel approach using low dose immunotherapy, which was very affordable and this was added to her chemotherapy regimen. Following three cycles of Immunotherapy and six cycles of chemotherapy a PET scan was done to assess the response to treatment. It was seen that the blood clots, along with the extensive metastatic disease in the lungs, abdomen, pelvis and liver had disappeared suggesting a complete/ near complete response of this deadly disease to the given therapy. She has recovered well and is now back to her country with recommendation to continue immunotherapy there. She is now without any symptoms and leading a normal, healthy active life.” Both Dr Ajay Gupta and Dr Shuaib Zaidi are elated with these results and feel that it is indeed heartening that the latest advances in immunotherapy in combination with conventional chemotherapy are having such a significant, positive impact in patient’s life at a cost they can afford.

Management of Aortic Aneurysm & Dissection Surgery Conclave 2022 was organized by Apollo Hospitals in Chennai. The conclave aimed at bringing national and international experts from across the India and the Globe to deliver their thoughts, applications, and advances in aortic and vascular surgery. The Institute of Aortic Surgery and Dissection surgery was inaugurated during this conclave by Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Group. This institute would focus on prevention and treatment of major aortic disease in the community by creating awareness in high risk population. Reputable National & International Faculty including Dr Khamin Chinsakcahi, Associate Professor in Vascular Surgery, Siriraj Hospital-Mahidol University, Bangkok – Thailand, Dr Shiv Chaudary, Professor & Head of the Department of Cardiothoracic Surgery, All India Institute of Medical Sciences, New Delhi, Dr Anil Bhan, Senior Consultant Cardiothoracic Surgeon, Medanta Hospital, New Delhi and Dr George Joseph, Senior Intervention Cardiologist, Christian Medical College, Vellore were an integral part of this one day conclave. Read More about the Management of Aortic Aneurysm & Dissection Surgery Conclave 2022

Apollo Institute of Orthopedics, a dedicated Centre for joint replacements, has successfully completed 370 robotic Orthopedics procedures over ten months since the launch. The Apollo Institute of Orthopedics began offering cutting-edge minimally invasive robotic surgical techniques and technology, since January 2022. Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Group said, “At Apollo, we are bringing in cutting edge medical technology, representing the next era of healthcare innovation to treat patients. Robotic Orthopedic procedures have helped us in helping the patient’s recovery from joint and knee ailments with ease. This center has become the busiest center by already completing 370 robotic knee replacement procedures since January 2022. Dr. Madan Mohan Reddy and his team, now holds the distinction of completing the maximum robotic knee replacements in the state of Tamil Nadu.” Read More about the achievement of Robotic Knee Replacements

Apollo Hospitals Group has launched its indigenously developed automated, rapid-response patient monitoring system. The system is designed to monitor and will proactively alert a team of experts if it anticipates an unexpected deterioration in patient health. This will dramatically improve timely intervention with the right experts thus ensuring significant improvement in patient’s condition management and health outcome. Speaking on the launch, Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said “Apollo has always been the pioneer in bringing the best and most relevant technologies to provide our patients with the best care in the world. This indigenously designed automated, rapid-response system is another step in this direction. Only Apollo Hospitals, with its vast experience in remote health care along with best-in-class clinical talent can design and build such a system for India. I am really excited to bring this innovation to our customers and help them get healthy quicker and live higher quality lives.” Apollo’s technology enabler Health Net Global has developed this custom designed state of the art remote and continuous monitoring platform integrated with advanced medical devices and wearables that transmits patient health data and provides easy access to the care providers at 3 different levels to ensure no critical event is missed and patient safety is ensured. The platform access enables Nurses, Pre MET team as well as Doctors to monitor patient health from Nurse stations, their mobiles and also from a regional command center. Its AI enabled early warning score and alert system helps timely intervention of clinicians thus providing enhanced care to patients. The monitoring system platform has been trained on Apollo’s vast and comprehensive remote-health program and has been on field trials across Hyderabad and Chennai. Within 2 months of trial, both centers have seen the system to provide efficiency in nursing care and reduction in unexpected complications. The system is a combination of hardware, advanced software directly integrated into the patient’s monitoring systems coupled with highly trained healthcare experts working in tandem to provide the most sophisticated monitoring system, backed up by rapid clinical response.

An 87-year-old woman from Karjat travelled to Apollo Hospitals, Navi Mumbai with an MRI report of her liver. She was diagnosed with a tumor of melon size in the left lobe of her liver. A timely hepatectomy by a multidisciplinary team of doctors at Apollo Hospitals, Navi Mumbai gave her a new lease of life. The massive tumor in her liver was compressing her stomach making her unable to eat. She was also thin and frail with a single kidney and hypertension making her health condition critical and a high risk for surgery. Dr Shailesh Sable, Lead Transplant Surgeon, Apollo Hospitals, Navi Mumbai, said, “Her family was keen on improving her health condition and did not think of her age and co-morbidities as a limitation. She was at a high risk of morbidity and mortality. Nevertheless, her family wanted to get rid of the tumor as it was affecting her lifestyle significantly. I agreed to let her undergo the process of tumor evaluation and fitness tests which she passed effortlessly.” After several iterations with a multidisciplinary team, she underwent a smooth surgery with no challenges during the surgery. The clinical team comprised Dr Shailesh Sable, Consultant, HPB & Liver Transplant Surgery, Dr Ketul Shah, Consultant, HPB & Liver Transplant Surgery, Dr. Makrand Karpe, Clinical Associate, Surgical Oncology, Dr Deep Mashru, Clinical Associate, Surgical Oncology, Dr. Ambreen Sawant, Anesthetist, Dr Pinky, Anesthetist, Dr Gunadhar Padhi, Consultant, Critical Care Specialist, Dr Suvadeep Sen, Consultant, Critical Care Specialist and the nursing and physiotherapy staff. She was put on intensive care and was back on her feet on day two of post-surgery. A week later on her follow-up visit to the doctor, she even brought indigenous sweets made by her for the doctors. Mr. Santosh Marathe, Regional CEO, said, “A lot can be learned from the elderly lady. She proves that age is just a number and that a positive attitude and active lifestyle along with an excellent clinical team can return one’s independence even at later stages in life. We are the first hospital in Western India to perform such a major Liver resection for liver cancer in an octogenarian patient. This is because Apollo Hospitals, Navi Mumbai is equipped with the latest state-of-the-art technology and clinical talent to undertake difficult surgeries and produce excellent outcomes.”